Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine.

Authors:
Torres Crigna A; Link B; Samec M; Giordano FA; Kubatka P and 1 more

Journal:
EPMA J

Publication Year: 2021

DOI:
10.1007/s13167-021-00248-z

PMCID:
PMC8334338

PMID:
34367381

View on PubMed View on PMC View Publisher
Journal Information

Full Title: EPMA J

Abbreviation: EPMA J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine, Research & Experimental

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Promoting advanced medical services in the framework of 3PM-a proof-of-concept by the "Centro" Regi…
Regateiro FJ; Silva H; Lemos MC and 7 more (2024) - Transparency Score: 3/6
Artificial intelligence to improve ischemia prediction in Rubidium Positron Emission Tomography-a v…
Frey SM; Bakula A; Tsirkin A and 13 more (2023) - Transparency Score: 3/6
Identification of potential necroinflammation-associated necroptosis-related biomarkers for delayed…
Bi Q; Wu JY; Qiu XM and 4 more (2023) - Transparency Score: 3/6
Integrating oculomics with genomics reveals imaging biomarkers for preventive and personalized pred…
Huang Y; Li C; Shi D and 16 more (2023) - Transparency Score: 4/6
Mechanical power normalized to aerated lung predicts noninvasive ventilation failure and death and …
Musso G; Taliano C; De Iuliis M and 9 more (2023) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare no competing interests."

Evidence found in paper:

"Funding Open Access funding enabled and organized by Projekt DEAL. Open Access funding enabled and organised by Projekt DEAL. The present study was supported by the LISPER project (grant Nr. 313011V446) in a bilateral agreement with the European Association for Predictive, Preventive and Personalised Medicine."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025